Table 1.
Bevacizumab impact on A549 cell proliferation (x ± s, n=9)
Groups | Concentration (μM) | 12 h | 24 h | 48 h | 72 h |
---|---|---|---|---|---|
| |||||
OD value | OD value | OD value | OD value | ||
Control Experimental | 0 | 0.486 ± 0.026 | 0.491 ± 0.019 | 0.496 ± 0.027 | 0.502 ± 0.023 |
1 | 0.487 ± 0.016 | 0.479 ± 0.017 | 0.469 ± 0.021 | 0.464 ± 0.031 | |
5 | 0.464 ± 0.014 | 0.440 ± 0.016 | 0.425 ± 0.020 | 0.408 ± 0.027 | |
25 | 0.446 ± 0.023 | 0.425 ± 0.022 | 0.360 ± 0.035 | 0.327 ± 0.031 |
Note: CCK 8 method is used to detect the OD value of each group A549 cells. Data are presented as the mean ± S. E. Data using analysis of variance of repeated measurement data.